| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34849667_HAS_TOPIC_C0001578> <https://research.tib.eu/covid-19/entity/34849667_HAS_TOPIC_C0001588> <https://research.tib.eu/covid-19/entity/34849667_HAS_TOPIC_C0001589> <https://research.tib.eu/covid-19/entity/34849667_HAS_TOPIC_C0008059> <https://research.tib.eu/covid-19/entity/34849667_HAS_TOPIC_C0027059> <https://research.tib.eu/covid-19/entity/34849667_HAS_TOPIC_C0031046> <https://research.tib.eu/covid-19/entity/34849667_HAS_TOPIC_C0035696> <https://research.tib.eu/covid-19/entity/34849667_HAS_TOPIC_C0068927> <https://research.tib.eu/covid-19/entity/34849667_HAS_TOPIC_C0071504> <https://research.tib.eu/covid-19/entity/34849667_HAS_TOPIC_C0086287> <https://research.tib.eu/covid-19/entity/34849667_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34849667_HAS_TOPIC_C0086582> <https://research.tib.eu/covid-19/entity/34849667_HAS_TOPIC_C0087178> <https://research.tib.eu/covid-19/entity/34849667_HAS_TOPIC_C0137714> <https://research.tib.eu/covid-19/entity/34849667_HAS_TOPIC_C0205653> <https://research.tib.eu/covid-19/entity/34849667_HAS_TOPIC_C0242494> <https://research.tib.eu/covid-19/entity/34849667_HAS_TOPIC_C0869523> <https://research.tib.eu/covid-19/entity/34849667_HAS_TOPIC_C1167732> <https://research.tib.eu/covid-19/entity/34849667_HAS_TOPIC_C1521910> <https://research.tib.eu/covid-19/entity/34849667_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34849667_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/34849667_HAS_TOPIC_C5387588> <https://research.tib.eu/covid-19/entity/34849667_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital (CHU), 37 Allées Jules Guesde, F-31000 Toulouse, France.\', \'Team PEPSS (Pharmacologie En Population cohorteS et biobanqueS), Centre d\'Investigation Clinique 1436, Toulouse University Hospital, France.\', \'Department of Cardiology, Faculty of Medicine, Toulouse University Hospital (CHU), Toulouse, France.\', \'INSERM U1219, Bordeaux Population Health, Team Pharmacoepidemiology, University of Bordeaux, F-33000 Bordeaux, France.\', \'Medical Pharmacology Unit, Public Health Division, Bordeaux University Hospital (CHU), F-33000 Bordeaux, France.\', \'Centre of Pharmacovigilance, Department of Clinical Pharmacology, Lille University, Lille University Hospital, F-59045 Lille, France.\', \'Department of Pharmacology and Pharmacovigilance, Pasteur Hospital Center of Nice, Nice University Hospital, F-06001 Nice Cedex 01, France.\', \'Pediatric Cardiology Unit, Children Hospital, CHU Toulouse, 330 Avenue de Grande Bretagne TSA 70034, F-31059 Toulouse Cedex 9, France.\', \'Institut Des Maladies Métaboliques et Cardiovasculaires, Université de Toulouse, INSERM U1048, I2MC, Toulouse, France.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/De_Paoli_Pierre> <https://research.tib.eu/covid-19/entity/Delmas_Cl%C3%A9ment> <https://research.tib.eu/covid-19/entity/Drici_Milou-Daniel> <https://research.tib.eu/covid-19/entity/Flumian_Clara> <https://research.tib.eu/covid-19/entity/Foltran_D%C3%A9borah> <https://research.tib.eu/covid-19/entity/Gautier_Sophie> <https://research.tib.eu/covid-19/entity/Karsenty_Cl%C3%A9ment> <https://research.tib.eu/covid-19/entity/Montastruc_Fran%C3%A7ois> <https://research.tib.eu/covid-19/entity/Salvo_Francesco>
?:doi	10.1093/ehjqcco/qcab090
?:doi	<https://research.tib.eu/covid-19/entity/10.1093/ehjqcco/qcab090>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Observational_Study> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t>
?:journal	European heart journal. Quality of care & clinical outcomes
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34849667>
?:pmid	<https://research.tib.eu/covid-19/entity/34849667>
?:pmid	34849667
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0027059_PROCESS_OF_C0205653> <https://research.tib.eu/covid-19/entity/C0027059_PROCESS_OF_C2348001> <https://research.tib.eu/covid-19/entity/C0042210_PREDISPOSES_C0031046>
?:title	Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2022

Property

Value

is ?:annotates of

?:authorAffiliation

[\'Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital (CHU), 37 Allées Jules Guesde, F-31000 Toulouse, France.\', \'Team PEPSS (Pharmacologie En Population cohorteS et biobanqueS), Centre d\'Investigation Clinique 1436, Toulouse University Hospital, France.\', \'Department of Cardiology, Faculty of Medicine, Toulouse University Hospital (CHU), Toulouse, France.\', \'INSERM U1219, Bordeaux Population Health, Team Pharmacoepidemiology, University of Bordeaux, F-33000 Bordeaux, France.\', \'Medical Pharmacology Unit, Public Health Division, Bordeaux University Hospital (CHU), F-33000 Bordeaux, France.\', \'Centre of Pharmacovigilance, Department of Clinical Pharmacology, Lille University, Lille University Hospital, F-59045 Lille, France.\', \'Department of Pharmacology and Pharmacovigilance, Pasteur Hospital Center of Nice, Nice University Hospital, F-06001 Nice Cedex 01, France.\', \'Pediatric Cardiology Unit, Children Hospital, CHU Toulouse, 330 Avenue de Grande Bretagne TSA 70034, F-31059 Toulouse Cedex 9, France.\', \'Institut Des Maladies Métaboliques et Cardiovasculaires, Université de Toulouse, INSERM U1048, I2MC, Toulouse, France.\']

?:citedBy